This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Pfizer files US court challenge to Novo's bid for Metsera

( November 3, 2025, 18:17 GMT | Official Statement) -- MLex Summary: Pfizer filed a US complaint against Novo Nordisk, Metsera, and three investment funds to enjoin Novo’s competing bid for Metsera, calling it “one of the most cynical and anticompetitive mergers ever contemplated.” According to the complaint, the deal, which may never close and could be pending for two-and-a-half years, is structured to give Novo enormous influence over Metsera without any antitrust approval and can forestall the competitive threat Novo faces for years, if not for good.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login